Gastric cancer often develops through a gradual sequence of changes, beginning with superficial gastritis and advancing through chronic atrophic gastritis, intestinal metaplasia, and precancerous ...

The data is yet more evidence that utilities need to install water filtration systems that can effectively reduce harmful water contaminants, says a science analyst. Ajax9 via Getty Images Truthout is ...

What could GLP-1 drugs, known for their powerful weight loss benefits, have to do with oncology? Potentially “everything,” according to Deborah Phippard, chief scientific officer at the clinical ...

DO-2 is a Best in Class MET kinase inhibitor that completed enrolling a Phase 1 dose escalation study. Tumour shrinkage is observed in 100% of MET exon 14 skip NSCLC patients without additional ...

DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), an AI-driven clinical -stage oncology company developing targeted therapies for cancer that are being advanced using its proprietary ...

Drugs that interrupt the death of healthy bone cells and induce the death of cancerous cells located in bones can prevent or reduced cancer associated bone weakness and improve treatment outcomes for ...

Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People’s Hospital, and Cancer Center, School of Medicine, Tongji University, Shanghai 200434, China Zhongshan ...

A newly mapped neural circuit shows how our skin senses cool temperatures and sends that info to the brain, revealing an unexpected amplifier in the spinal cord and offering insight into cold-related ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Drug resistance critically limits the ...

Primary results from the phase 2 RAMP 201 trial (NCT04625270) evaluating the combination therapy of avutometinib and defactinib (Avmapki Fakzynja co-pack) for patients with KRAS-mutated recurrent ...